Evidence map›Paper›PMID 38987501›Full record

ArticleLa Radiologia medica2024

Evaluating the impact of delayed-phase imaging in Contrast-Enhanced Mammography on breast cancer staging: A comparative study of abbreviated versus complete protocol.

Naomi Calabrò, Flavia Abruzzese, Eleonora Valentini, Anna Clelia Lucia Gambaro, Silvia Attanasio, Barbara Cannillo, Marco Brambilla, Alessandro Carriero

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in La Radiologia medica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Contrast-enhanced mammography in high-dense breasts: a narrative review.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Naomi CalabròSCDU Radiodiagnostica, Ospedale Maggiore Della Carità, 28100, Novara, Italy. naomi.calabro93@gmail.com.ORCID http://orcid.org/0000-0002-2806-6330
Flavia AbruzzeseSCDU Radiodiagnostica, Ospedale Maggiore Della Carità, 28100, Novara, Italy.
Eleonora ValentiniSCDU Radiodiagnostica, Ospedale Maggiore Della Carità, 28100, Novara, Italy.
Anna Clelia Lucia GambaroSCDU Radiodiagnostica, Ospedale Maggiore Della Carità, 28100, Novara, Italy.
Silvia AttanasioSCDU Radiodiagnostica, Ospedale Maggiore Della Carità, 28100, Novara, Italy.
Barbara CannilloSCDO Fisica Sanitaria, Ospedale Maggiore Della Carità, 28100, Novara, Italy.
Marco BrambillaSCDO Fisica Sanitaria, Ospedale Maggiore Della Carità, 28100, Novara, Italy.
Alessandro CarrieroDipartimento Di Medicina Translazionale, Università del Piemonte Orientale, 28100, Novara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeContrast-enhanced mammography (CEM) is an innovative imaging tool for breast cancer detection, involving intravenous injection of a contrast medium and the assessment of lesion enhancement in two phases: early and delayed. The aim of the study was to analyze the topographic concordance of lesions detected in the early- versus delayed phase acquisitions. MATERIALS AND

methodsApproved by the Ethics Committee (No. 118/20), this prospective study included 100 women with histopathological confirmed breast neoplasia (B6) at the Radiodiagnostics Department of the Maggiore della Carità Hospital of Novara, Italy from May 1, 2021, to October 17, 2022. Participants underwent CEM examinations using a complete protocol, encompassing both early- and delayed image acquisitions. Three experienced radiologists blindly analyzed the CEM images for contrast enhancement to determine the topographic concordance of the identified lesions. Two readers assessed the complete study (protocol A), while one reader assessed the protocol without the delayed phase (protocol B). The average glandular dose (AGD) of the entire procedure was also evaluated.

resultsThe analysis demonstrated high concordance among the three readers in the topographical identification of lesions within individual quadrants of both breasts, with a Cohen's κ > 0.75, except for the lower inner quadrant of the right breast and the retro-areolar region of the left breast. The mean whole AGD was 29.2 mGy. The mean AGD due to CEM amounted to 73% of the whole AGD (21.2 mGy). The AGD attributable to the delayed phase of CEM contributed to 36% of the whole AGD (10.5 mGy).

conclusionsAs we found no significant discrepancy between the readings of the two protocols, we conclude that delayed-phase image acquisition in CEM does not provide essential diagnostic benefits for effective disease management. Instead, it contributes to unnecessary radiation exposure.

Indexed as

Breast NeoplasmsContrast MediaMammographyNeoplasm StagingAdultAgedAged, 80 and overFemaleHumansMiddle AgedProspective StudiesRadiographic Image EnhancementContrast MediaBreast cancerBreast lesionContrast-Enhanced mammographyDual-Energy contrast-Enhanced spectral mammographyInter-Observer agreement

Identifiers

PMID38987501
PMCPMC11252175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.